Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
Study Site(s), number of subjects planned Number of study sites planned for this research study (scheduled) 60 (undetermined) Number of subjects planned for this research study (scheduled) 1,100 patients
Age
40–150
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with a diagnosis of COPD (FEV1/FVC\<0.7 confirmed based on the past medical records)
Patients aged 40 years and over at the diagnosis of COPD
Outpatient
10 or more pack-years of current or former smokers
Patients who have traceable medical records of COPD (including the results of spirometry) going back more than a year
Patients who meet any of the following two criteria
1. Patients who have medical records of the results of spirometry at more than two different time points excluding the time point of COPD exacerbations\* for the past 3 years
2. Patients who can provide the results of reversibility testing for respiratory tract
Patients who give written informed consent regarding the participation in this study
You may not be if
Patients currently with COPD exacerbations
Patients who currently enroll in the other interventional study including clinical trials
Patients who concurrently develop or have a history of lung cancer
Patients who are disabled to understand the study procedure or answer the questionnaire (i.e. due to the history of alcohol or drug abuse)
Clareo Health | High Risk Populations Among COPD Patients in Japan
